Corteva, Inc. CTVA
Set alert
11.92 USD +0.28 +2.41%
At close
11.80 -0.12 -1.01%
Pre-market · Nov 3, 8:18 AM ET
11.52 Day range 12.02
9.19 52-week range 14.62
- YTD
- +18.49%
- 1 year
- +28.03%
- Open
- 11.61
- Prev close
- 11.64
- Mkt cap
- 7.95B
- Vol
- 20.39M
- Avg vol
- 32.75M
- EPS
- 1.62
- P/E
- 7.36
- Div yield
- 6.28%
More statistics
- Low
- 11.52
- High
- 12.02
- Forward P/E
- 10.59
- Beta
- 0.00
- Short ratio
- 1.38
- Inst. own
- 92.79%
- Dividend
- 0.72
- Ex-div date
- Nov 30, 2026
- Earnings
- Nov 11, 2026
- 50-d avg
- 12.54
- 200-d avg
- 12.09
- 1y target
- 17.13
3M chart
Events in this range
- Sep 1, 2026Dividend: 0.18
- Sep 16, 2026Rating: BMO Capital · Outperform → Outperform
- Sep 17, 2026Rating: Citigroup · Neutral → Neutral
- Sep 18, 2026Rating: Argus Research · Buy → Buy
- Oct 6, 2026Rating: JP Morgan · Neutral → Overweight
- Oct 7, 2026Rating: Keybanc · Sector Weight → Overweight
- Oct 12, 2026Rating: UBS · Neutral → Neutral
Signals (20)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 19, 2026 | 2 weeks ago |
| RSI: Overbought | Oct 7, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 6, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| MACD: Buy Signal | Oct 5, 2026 | 4 weeks ago |
| SMA: Bearish | Oct 2, 2026 | 1 month ago |
| SMA: Bearish | Oct 2, 2026 | 1 month ago |
| SMA: Bullish | Oct 1, 2026 | 1 month ago |
| SMA: Bullish | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 16, 2026 | 1 month ago |
| SMA: Bearish | Sep 16, 2026 | 1 month ago |
| SMA: Bullish | Sep 15, 2026 | 1 month ago |
| SMA: Bearish | Sep 14, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 14, 2026 | 1 month ago |
| RSI: Overbought | Sep 2, 2026 | 2 months ago |
| SMA: Bullish | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 24, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 20, 2026 | 2 months ago |
Analyst view
Consensus: buy
Buy
Price target (mean) 17.13 +43.7% upside
Now 11.92
- Target (low)
- 13.65
- Target (mean)
- 17.13
- Target (high)
- 20.00
Ratings (0m) 13 11 buy · 2 hold · 0 sell
- Strong buy3
- Buy8
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 13
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.09571 | 0.00 – 0.1809 | 0.00 | 0.0% | 1.77B | 0.0% | 6 |
| Next quarter | 0.2576 | 0.22 – 0.32003 | 0.00 | 0.0% | 2.31B | 0.0% | 5 |
| Current year | 1.07 | 0.64774 – 1.96 | 0.00 | 0.0% | 7.81B | 0.0% | 8 |
| Next year | 1.12 | 0.85262 – 1.42 | 1.07 | +4.7% | 8.06B | +3.1% | 9 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 12, 2026 | UBS | Maintained | Neutral | Neutral |
| Oct 7, 2026 | Keybanc | Upgrade | Sector Weight | Overweight |
| Oct 6, 2026 | JP Morgan | Upgrade | Neutral | Overweight |
| Sep 18, 2026 | Argus Research | Reiterated | Buy | Buy |
| Sep 17, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Sep 16, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Sep 16, 2026 | UBS | Maintained | Neutral | Neutral |
| Sep 16, 2026 | RBC Capital | Reiterated | Outperform | Outperform |
| Sep 11, 2026 | Keybanc | Initiated | — | Sector Weight |
| Aug 18, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 3, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 3, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Aug 3, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Aug 3, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Jul 23, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Jul 21, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 20, 2026 | B of A Securities | Maintained | Buy | Buy |
| Jul 14, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jul 2, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jun 11, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jun 9, 2026 | UBS | Maintained | Neutral | Neutral |
| May 28, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| May 7, 2026 | UBS | Maintained | Neutral | Neutral |
| May 7, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Apr 24, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Apr 22, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Apr 21, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Apr 9, 2026 | UBS | Maintained | Neutral | Neutral |
| Mar 31, 2026 | Argus Research | Maintained | Buy | Buy |
| Feb 17, 2026 | Mizuho | Maintained | Outperform | Outperform |
